$24,441.90 consulting Payment -- Novartis Pharmaceuticals to Dr. Sarah Chen

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Novartis Pharmaceuticals made a $24.4K consulting payment to Sarah Chen, a Ophthalmology specialist in City, CO. The payment was associated with Humira. Sarah Chen received a $24,441.90 consulting fee from Novartis Pharmaceuticals on September 8, 2025. The payment was related to consulting services for the drug Humira. This payment represents a significant financial engagement between the pharmaceutical company and the ophthalmologist.

Patient Guidance: What This Payment Means for You

Patients should be aware that their ophthalmologists may receive payments from pharmaceutical companies for consulting services, which could potentially influence treatment recommendations. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Consulting fees of this magnitude are not uncommon in specialized fields like ophthalmology, where expert advice on specific drugs or devices is highly valued by pharmaceutical companies.

Regulatory Context: Sunshine Act Requirements

This payment falls under the Sunshine Act provisions of the Affordable Care Act, requiring disclosure of financial relationships between drug manufacturers and healthcare providers.

Related Topics

This payment is related to the following healthcare transparency topics:

• ophthalmology
• consulting-fee
• pharmaceutical-payment
• novartis
• humira
• physician-payment

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

What was this $24.4K payment for?

This was a consulting payment of $24.4K from Novartis Pharmaceuticals to Sarah Chen, categorized as "Consulting Fee". It was associated with Humira. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Sarah Chen accept pharmaceutical money?

Yes, Sarah Chen received this $24.4K payment from Novartis Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Sarah Chen's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this consulting payment?

A consulting payment of $24.4K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Ophthalmology?

To compare this payment against Ophthalmology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Ophthalmology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Sarah Chen's relationship with Novartis Pharmaceuticals?

The payment amount is substantial, suggesting a significant consulting role. This $24.4K consulting payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Ophthalmology?

The specific drug mentioned, Humira, indicates a focus on treatments within ophthalmology.

What should patients do after learning about this payment?

Patients should be aware that their ophthalmologists may receive payments from pharmaceutical companies for consulting services, which could potentially influence treatment recommendations.

What else should I know about this consulting payment?

The payment date is in the future, which is unusual for a completed transaction.

Related Reports

• View Dr. Sarah Chen's full payment report
• Novartis Pharmaceuticals full spending report
• Browse all Ophthalmology payments
• Browse all payments in Colorado
• Search for other payments